Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.
about
Stem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart DefectsStem cell therapy and tissue engineering for correction of congenital heart diseaseBioengineering and the cardiovascular systemInduced pluripotent stem cell-derived vascular smooth muscle cells: methods and applicationCardiovascular tissue engineering: where we come from and where are we now?Smooth muscle and other cell sources for human blood vessel engineeringTissue engineering in the vasculatureScaffolds in vascular regeneration: current statusStem cell sources for vascular tissue engineering and regenerationMatrix production and organization by endothelial colony forming cells in mechanically strained engineered tissue constructsScaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat AortaeClinical translation of controlled protein delivery systems for tissue engineeringLong-term results of cell-free biodegradable scaffolds for in situ tissue-engineering vasculature: in a canine inferior vena cava modelThe Tissue-Engineered Vascular Graft-Past, Present, and Future.Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.Construction of tissue-engineered small-diameter vascular grafts in fibrin scaffolds in 30 daysDevelopment of Small-Diameter Vascular Grafts Based on Silk Fibroin Fibers from Bombyx mori for Vascular Regeneration.Biomaterials for vascular tissue engineeringInspiration and application in the evolution of biomaterials.In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model.Preparation of decellularized and crosslinked artery patch for vascular tissue-engineering application.Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials.Blood vessel-derived acellular matrix for vascular graft applicationMolecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering.Cell-seeding techniques in vascular tissue engineeringTissue-engineered vascular grafts: does cell seeding matter?Implantation of inferior vena cava interposition graft in mouse modelStem cell-derived endothelial cells for cardiovascular disease: a therapeutic perspective.The significance of pore microarchitecture in a multi-layered elastomeric scaffold for contractile cardiac muscle constructsHydrostatic pressure independently increases elastin and collagen co-expression in small-diameter engineered arterial constructs.Comparison of a closed system to a standard open technique for preparing tissue-engineered vascular graftsTissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vesselArtificial niche combining elastomeric substrate and platelets guides vascular differentiation of bone marrow mononuclear cells.Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation methodDevelopment of small diameter nanofiber tissue engineered arterial grafts.Tissue engineering of blood vessel.Challenges in translating vascular tissue engineering to the pediatric clinic.A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts.Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRIThe innate immune system contributes to tissue-engineered vascular graft performance.
P2860
Q26785527-779BF969-3940-402B-A95C-E0BCA30F5D29Q26801514-2784221D-1238-4E04-B195-0D18ED6FEBF4Q26827097-FF9DABD5-FA5F-4A9E-B008-26970C184E51Q26853054-09158222-6A75-4739-84CB-41CB67D82213Q26853338-C5C1E575-69F9-48B4-A07A-2656BCB9CC18Q26862581-5C5299F3-BF72-4EE8-8D9C-27F2377F9DC6Q26999017-651E4DF0-6C8C-4AA0-86A5-7E6811B00472Q27012628-404224FF-9E61-407E-AE74-CD96B6A2EBD4Q27028106-98436751-6F89-486A-92C8-9E749C260989Q27308049-9E2FB240-AC5E-46E0-9F47-D0C6EF475115Q27321144-98B78F86-543E-4EE0-97F6-1771C0F017D5Q28084738-FCEA973B-99EB-483A-88E7-A46CC4B24521Q28482423-431D8E78-77DF-467D-B681-DC70C940E740Q30385854-54FE889A-0B56-447C-8950-AB0196330FABQ33537670-A6ECB61D-E3EA-437E-8028-753041C0B0FAQ33571735-22E3C6C7-4550-4E95-9618-C186B5CD79D4Q33608288-97EFBBD1-47E4-4572-B022-82C7F51389E9Q33655808-BED7BDCA-15E6-4E41-A551-E850722B8620Q33765529-782D3B8F-6367-4722-976B-05274DD40C1DQ33822574-0B991156-7DFF-439B-A754-5D780657B7F3Q33884441-CACF7AA7-8B51-4A38-8D66-4F21F6049308Q33994263-D604B804-B7DB-4876-8976-8BDDE022D8CBQ34014438-E4E4BC85-46C5-4734-B938-CD069C83071FQ34146262-A14F3771-8DFF-4BF6-860C-D28E22AAFD94Q34160631-2CD64F70-41FD-4327-9985-FA95F2228237Q34271210-4BB5A325-1024-4E88-A710-699CC8D5310DQ34293482-E00CFBBA-F285-45C0-8A41-6F89C8D7DB98Q34306425-45BFC170-DA5D-45F3-AC01-AC806501D158Q34535812-706B822A-7B22-49C0-B417-6E38FABABF91Q34598385-98B50B16-F076-48AE-BA0A-7F9A57979C12Q34920180-BA7855D5-9358-41CB-996F-433F6D9D6768Q35105356-D65F565A-80F5-4B49-BDD3-CBAA5388B12BQ35125074-4BDDF614-7224-4030-86B2-20AF311813C5Q35239498-175A54AA-4686-4CD3-9F22-AF8830E9FEB9Q35242269-11B473C1-1D68-4BFE-B07A-C74F9B062D72Q35459503-AF1904E5-CECA-40D3-ABB2-146491F36CB8Q35486978-C4356713-95A4-4C1D-8E56-7831F97937A8Q35609601-06086813-966D-433B-B279-9BCF26B735D7Q35609635-AAF9598A-641E-4906-8F73-F40060712C4BQ35660078-A80B6DBD-2272-4384-A526-AC5B2A4DCBC5
P2860
Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Midterm clinical result of tis ...... autologous bone marrow cells.
@en
Midterm clinical result of tis ...... autologous bone marrow cells.
@nl
type
label
Midterm clinical result of tis ...... autologous bone marrow cells.
@en
Midterm clinical result of tis ...... autologous bone marrow cells.
@nl
prefLabel
Midterm clinical result of tis ...... autologous bone marrow cells.
@en
Midterm clinical result of tis ...... autologous bone marrow cells.
@nl
P2093
P1476
Midterm clinical result of tis ...... autologous bone marrow cells.
@en
P2093
Goki Matsumura
Hiromi Kurosawa
Manabu Watanabe
Masayoshi Nagatsu
Narutoshi Hibino
Takahiko Sakamoto
Takeshi Konuma
Toshiharu Shin'oka
Yuji Naito
P304
P356
10.1016/J.JTCVS.2004.12.047
P407
P577
2005-06-01T00:00:00Z